4:05 PM ET
8-K
Other 8-K Filing
Glucotrack Other 8-K Filing
Glucotrack entered into a waiver agreement with warrant holders to terminate certain restrictive covenants and exercise price adjustment provisions from a July 2026 purchase agreement. In consideration for these waivers, the company agreed to issue new warrants to purchase 406,198 shares of common stock at an exercise price of $7.50 per share.